This journal publishes cutting-edge reviews on subjects pertinent to all aspects of stem cell research, therapy, ethics, commercialization, and policy. The contents are distinguished by their incisive, insightful, and balanced contributions from leading experts in each relevant domain. Leading authorities serve as Section Editors in key areas spanning the discipline, choosing topics for review by expert contributors. These reviews, along with commentaries from well-known figures in the field, will benefit a wide readership of clinicians, basic scientists and translational investigators.

  • An up-to-date source of reviews on all aspects of stem cell research
  • The contributors are leading experts in each relevant domain
  • Coverage includes stem cell research, therapy, ethics, commercialization and policy

Journal information

  • Gra├ža Almeida-Porada,
  • Diane Krause
Publishing model
Hybrid. Open Access options available

Journal metrics

56,546 (2019)

Latest articles

This journal has 32 open access articles


Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Dimensions
  4. EBSCO Discovery Service
  6. EMCare
  7. Emerging Sources Citation Index
  8. Google Scholar
  9. Institute of Scientific and Technical Information of China
  10. Japanese Science and Technology Agency (JST)
  11. Meta
  12. Naver
  13. OCLC WorldCat Discovery Service
  14. ProQuest Biological Science Database
  15. ProQuest Central
  16. ProQuest Natural Science Collection
  17. ProQuest SciTech Premium Collection
  18. ProQuest-ExLibris Primo
  19. ProQuest-ExLibris Summon
  20. Reaxys
  21. SCImago
  22. SCOPUS
  23. TD Net Discovery Service
  24. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG